Skip to content
All speakers

Abdulaziz Elgammal

Role
Co-founder & CPO of Proteinea
Organisation
Proteinea
Where to catch them
Abdulaziz Elgammal

About

Abdulaziz Elgammal is the Co-Founder and Chief Product Officer at Proteinea, an AI-native drug development company building an “evergreen” engine for therapeutic asset creation, with a core focus on engineering next generation antibody therapeutics. He works at the intersection of deep tech and biotech, translating frontier AI capabilities into real-world R&D products, partnerships, and investable pipelines. At Proteinea, Abdulaziz leads product strategy and execution across platform development and partner-facing programs. His work focuses on building repeatable, de-risked systems that can continuously generate high-value therapeutic candidates, helping position the company as a long-term biotech powerhouse in the MEA region. He is passionate about how capital, incentives, and product thinking shape the trajectory of deep tech startups, especially in domains where timelines are long, technical risk is real, and the reward is outsized impact. When he’s not thinking about molecules and models, you’ll likely find him in Cairo hunting for a great coffee, taking long city walks, and collecting stories from founders who are brave enough to build the future early.

Where to catch Abdulaziz

1 appearance over 1 day, in running order. Headline-stage sessions are marked in navy.

Full agenda

Day 1

Thursday

5 February1 slot

  1. 18:15to 18:45

    Debate

    The Funding Blind Spot: Are Deeptech Startups Overlooked?

    Capital Stage

    +1

    5 Speakers

Also on the bill

All speakers

26–28 December 2026 · Cairo

The Turning Point

Three days with thousands of people who are building the future of business, technology and culture.